Medicare Part D launched the GLP-1 Bridge program on July 1, 2026, covering Wegovy (injection and tablet), Zepbound (KwikPen only), and Foundayo for weight management at $50/month through December 31, 2027
Whether youre debating trying weight loss medication or are exploring available treatment options, keep reading to discover why Wegovy could be a powerful ally as you embark on your journey
Picture this: you've tried every diet under the sun, hit the gym religiously, but the pounds just won't budge
Sleep, Stress, and Alcohol Sleep quality, stress levels, and alcohol intake all influence hormones involved in metabolism and appetite regulation
Therefore, caffeine intake does not impact the medications initial absorption or therapeutic action
Some people reach a dose where they feel consistent appetite control without needing to go higher